Table 2.
Different coating and doping materials for iron oxide nanoparticles
S no | Coating and doping materials | Advantages | Disadvantages | References |
---|---|---|---|---|
Polymer coatings over iron oxide | ||||
1 | Poly (D,L-lactide) | Enhanced biocompatibility | Usually very unstable (affected with varying pH and temperature); agglomeration and adherence property (causing toxic and immunogenic effects); inside body system, hydrodynamic flow retards its movement (mostly dissolved in body fluids and degradation due to enzyme activity) | 13, 14 |
2 | Polyacrylic acid | Improves bioadhesion | 15, 16 | |
3 | Phosphorylcholine | Initiates coagulation | 17 | |
4 | Polyvinyl pyrrolidone | Improves functionalization | 18 | |
5 | Polyvinyl alcohol | Increases monodisperse particle formation | 19–22 | |
6 | Polyethylene glycol | Improves biocompatibility | 23, 24 | |
7 | Dextran | Biocompatible, controlling particle size and shapes | 25, 26 | |
8 | Polystyrene | Uniform cluster formation, controlling particle size and shapes | 27 | |
9 | Starch | Biocompatible, coating material | 28, 29 | |
10 | Ethyl cellulose | Enhances drug uptake, good functional property | 30, 31 | |
11 | Gelatin | Natural, biocompatible | 32–34 | |
12 | Chitosan | Natural, biocompatible | 35 | |
13 | Fatty acids | Terminal group functionalization, biocatalyst | 36, 37 | |
14 | Bovine serum albumin | Biocompatible | 38 | |
15 | Folic acid | Targets cancer cells, less immunogenic | 39 | |
16 | Insulin | Improves gene therapy | 40 | |
17 | Liposome | Long circulatory time in body system | 41 | |
Metal and metal oxide coatings over iron oxide | ||||
1 | Gold | Enhances optical properties and stabilization | Toxic effects, fabrication difficulties, and cost associated with its synthesis | 42, 43 |
2 | Silver | Enhances optical properties and antimicrobial activity | 44 | |
3 | Platinum | Enhances optical and electrochemical properties | 45 | |
4 | Zinc | Enhances magnetic property | 46 | |
5 | SiO2 | Increases surface area and binding affinity | Increases oxidative stress and agglomerates | 47, 48 |
6 | TiO2 | Photocatalytic activity | Nonbiological application only | 49 |
7 | Calcium phosphate coating | Biocompatible, osteoconductive | Difficult to control coating layer thickness | 50 |
8 | Hydroxyapatite | Biocompatible, stable, osteoconductive | Difficult to control coating layer thickness | 65–107 |